Undescended testis (UDT) is one of the most frequent urogenital abnormalities, and can be of congenital or acquired origin. The problem with most literature is that since acquired UDT was only recently accepted as a distinct entity, it does not discriminate between congenital and acquired UDT. For congenital UDT much is known on the aetiology, natural course, and treatment, however, these matters are less clear for acquired UDT.

, , , ,
C.H. Bangma (Chris) , F.W.J. Hazebroek (Frans) , G.R. Dohle (Gert) , S.M.P.F. de Muinck Keizer-Schrama (Sabine)
The printing of this thesis was financially supported by: Astellas Pharma B.V., Astrazeneca, AbbVie, Chipsoft B.V., Coloplast, Goodlife Pharma, Kyowa Kirin Pharma B.V., Olympus Nederland B.V., Pohl Boskamp B.V., SUWO, SWOP.
Erasmus University Rotterdam
Department of Dermatology

van Brakel, J. (2016, September 21). Treatment of Congenital and Acquired Undescended Testes. Retrieved from http://hdl.handle.net/1765/93290